Video Experimental Relacionado

Updated: Jul 12, 2026

Interview: HIV-1 Proviral DNA Excision Using an Evolved Recombinase
10:20

Interview: HIV-1 Proviral DNA Excision Using an Evolved Recombinase

Published on: June 16, 2008

¿Podrían los tratamientos para el SIDA escapar a través de las lagunas de las patentes?

P Smaglik

    Nature
    |April 4, 2000
    PubMed
    Resumen

    No abstract available in PubMed .

    Más Videos Relacionados

    Engineering Antiviral Agents via Surface Plasmon Resonance13:00

    Engineering Antiviral Agents via Surface Plasmon Resonance

    Published on: June 14, 2022

    Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus (AAV) Capsid Variants09:20

    Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus (AAV) Capsid Variants

    Published on: October 18, 2022

    Videos de Conceptos Relacionados

    Antiviral Nucleoside Inhibitors01:22

    Antiviral Nucleoside Inhibitors

    Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...